Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
STSS Sharps Technology
- 0.285
- -0.019-6.35%
Close Feb 28 16:00 ET
- 0.281
- -0.004-1.26%
Post 19:58 ET
4.65MMarket Cap-0.03P/E (TTM)
0.313High0.280Low1.86MVolume0.313Open0.304Pre Close536.91KTurnover11.94%Turnover RatioLossP/E (Static)16.33MShares18.15452wk High0.72P/B4.43MFloat Cap0.26452wk Low--Dividend TTM15.56MShs Float79.640Historical High--Div YieldTTM10.86%Amplitude0.264Historical Low0.288Avg Price1Lot Size
About Sharps Technology Company
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features. The company was founded by Alan R. Blackman and Barry B. Berler on December 16, 2017 and is headquartered in Melville, NY.
Company Profile
SymbolSTSS
Company NameSharps Technology
Listing DateApr 14, 2022
Issue Price4.23
Founded2017
CEOMr. Robert M. Hayes
MarketNASDAQ
Employees57
Fiscal Year Ends12-31
Address105 Maxess Road,Suite 124
CityMelville
ProvinceNew York
CountryUnited States of America
Zip Code11747
Phone1-631-574-4436
Company Executives
- Name
- Position
- Salary
- Robert M. Hayes
- Chief Executive Officer and Director
- 788.97K
- Andrew R. Crescenzo
- Chief Financial Officer and Principal Accounting Officer
- 256.60K
- Dr. Soren Bo Christiansen
- Chairman of the Board
- 157.71K
- Timothy J. Ruemler
- Independent Director
- 103.14K
- Brenda Baird Simpson
- Independent Director
- 97.14K
- Paul K. Danner
- Independent Director
- 143.14K
- Jason L. Monroe
- Independent Director
- 103.14K